BIOFORCE NANOSCIENCES HOLDINGS, INC.: total assets
Total assets for BIOFORCE NANOSCIENCES HOLDINGS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BIOFORCE NANOSCIENCES HOLDINGS, INC. financial histories
What this measure means
Resources recognized on the balance sheet. Book assets are not the market value of the business.
Exact concept: us-gaap:Assets. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2017-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Reading these values
This selected numerical history matches Current assets for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 786 | USD | 2026-04-15 | 10-K · 0001091818-26-000047 |
| At date | 2024-12-31 | 862 | USD | 2026-04-15 | 10-K · 0001091818-26-000047 |
| At date | 2023-12-31 | 638 | USD | 2025-04-08 | 10-K · 0001091818-25-000036 |
| At date | 2022-12-31 | 734 | USD | 2024-04-01 | 10-K · 0001091818-24-000034 |
| At date | 2021-12-31 | 11,145 | USD | 2023-03-28 | 10-K · 0001091818-23-000044 |
| At date | 2020-12-31 | 39,865 | USD | 2022-02-11 | 10-K · 0001091818-22-000014 |
| At date | 2019-12-31 | 58,895 | USD | 2021-02-16 | 10-K · 0001091818-21-000016 |
| At date | 2018-12-31 | 35,127 | USD | 2020-03-09 | 10-K/A · 0001091818-20-000039 |
| At date | 2017-12-31 | 20,908 | USD | 2019-03-29 | 10-K · 0001091818-19-000088 |
Related financial histories
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: total liabilities
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: stockholders equity
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: cash and cash equivalents
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: net income or loss
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: operating cash flow
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: revenue
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: financing cash flow
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: retained earnings or deficit
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: basic weighted-average shares
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: diluted weighted-average shares
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: basic earnings per share
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: diluted earnings per share
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: operating income or loss
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: current assets
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: current liabilities
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: operating expenses
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: gross profit
- BIOFORCE NANOSCIENCES HOLDINGS, INC.: cost of revenue
Inspect the source
- Entity
- BIOFORCE NANOSCIENCES HOLDINGS, INC. / CIK 0001310488
- Captured
- 2026-09-20T07:51:22.180Z
- SEC response SHA-256
47abfb2c04ee0f344918ad7471fc3215ff4f2adbc98eefaf8e29b533441d63bf
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001310488.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))